Exploring the ARTEMIS 2 Study
Jason Bacharach, MD, sits down with Neda Shamie, MD, on Clinical Minute to discuss a randomized, 20-month, multicenter, masked, parallel-group, phase 3 trial that evaluated the IOP-lowering efficacy and safety of the bimatoprost implant (Durysta, Allergan) in patients with open-angle glaucoma or ocular hypertension.
Meeting Updates
- Glaucoma Research Foundation Glaucoma 360 & New Horizons Forum | February 2–4, 2023; Live in San Francisco
- AGS Annual Meeting | March 2–5, 2023; Live in Austin & Virtual
- YoungMD Connect Live | March 24–26, 2023; Live in Austin
- ASCRS Annual Meeting | May 5–8, 2023; Live in San Diego
Innovations in Ergonomics: Heads-Up Surgery
As Arjan Hura, MD, advanced through his training and early years in ophthalmology practice, he noticed his mentors and older colleagues regularly discussing the importance of establishing good surgical ergonomics. In this episode of Innovation Journal Club, Dr. Hura and I. Paul Singh, MD, discuss how being proactive about health and wellness is an investment in career longevity.
A Forum for the Future Leaders in Ophthalmology
MillennialEYE Live is now YoungMD Connect Live! This live meeting developed for the future leaders in ophthalmology will take place March 24–26, 2023, in Austin. Opportunities to mentor are available, as is a scholarship program for medical students, residents, and fellows. For more information, visit www.youngmdconnectlive.com.
IGC as Seen on Social
Stay tuned: More updates from the 2022 Interventional Glaucoma Consortium (IGC), held November 18–20 in Salt Lake City, will be featured in the next issue of GT!
